Conference
Renal cell carcinoma (RCC) primary tumor shrinkage on vascular endothelial growth factor (VEGF)-targeted therapy (TT): A pooled analysis.
Abstract
629
Background: Cytoreductive nephrectomy (CRN) is an important treatment modality in patients (pts) with advanced RCC, however the role and timing in the context of VEGF-TT remains under investigation. The aim of this study is to determine the efficacy of VEGF-TT to induce primary tumor shrinkage in advanced RCC. Methods: We conducted a pooled analysis of 12 Pfizer-sponsored trials in pts with metastatic RCC treated with …
Authors
Bosse D; Lin X; Simantov R; Lalani A-KA; Derweesh I; Chang SL; Choueiri TK; McKay RR
Volume
36
Pagination
pp. 629-629
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
February 20, 2018
DOI
10.1200/jco.2018.36.6_suppl.629
Conference proceedings
Journal of Clinical Oncology
Issue
6_suppl
ISSN
0732-183X